Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Essa Pharma Inc. (EPIX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Essa Pharma Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1633932.
Total stock buying since 2020: $15,437,647.
Total stock sales since 2020: $13,712,396.
Total stock option exercises since 2020: $427,003.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 156 | $292 | 0 | $0 |
| 2024 | 0 | $0 | 7,961,528 | $12,835,740 | 78,750 | $260,624 |
| 2023 | 108,953 | $574,147 | 0 | $0 | 0 | $0 |
| 2022 | 2,975,360 | $11,105,750 | 297,940 | $876,364 | 0 | $0 |
| 2021 | 307,000 | $3,757,750 | 0 | $0 | 0 | $0 |
| 2020 | 0 | $0 | 0 | $0 | 42,207 | $166,379 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 156 | $292 | 0 | $0 |
| 2024-11 | 0 | $0 | 7,879,583 | $12,016,364 | 0 | $0 |
| 2024-10 | 0 | $0 | 694 | $4,184 | 0 | $0 |
| 2024-09 | 0 | $0 | 2,776 | $16,718 | 0 | $0 |
| 2024-05 | 0 | $0 | 694 | $4,823 | 0 | $0 |
| 2024-04 | 0 | $0 | 694 | $5,510 | 3,750 | $18,375 |
| 2024-03 | 0 | $0 | 694 | $6,232 | 0 | $0 |
| 2024-02 | 0 | $0 | 73,976 | $760,442 | 73,282 | $236,700 |
| 2024-01 | 0 | $0 | 2,417 | $21,467 | 1,718 | $5,549 |
| 2023-12 | 9,223 | $21,212 | 0 | $0 | 0 | $0 |
| 2023-11 | 99,730 | $552,935 | 0 | $0 | 0 | $0 |
| 2022-12 | 81,604 | $198,708 | 272,840 | $729,429 | 0 | $0 |
| 2022-10 | 2,000,000 | $8,219,500 | 0 | $0 | 0 | $0 |
| 2022-07 | 888,869 | $2,673,087 | 0 | $0 | 0 | $0 |
| 2022-06 | 4,887 | $14,455 | 0 | $0 | 0 | $0 |
| 2022-04 | 0 | $0 | 25,100 | $146,935 | 0 | $0 |
| 2021-08 | 250,000 | $2,218,750 | 0 | $0 | 0 | $0 |
| 2021-02 | 57,000 | $1,539,000 | 0 | $0 | 0 | $0 |
| 2020-12 | 0 | $0 | 0 | $0 | 42,207 | $166,379 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-05 | Lampert Mark N | Sale | 156 | 1.88 | 292 |
| 2024-11-01 | Bb Biotech Ag | Sale | 7,879,583 | 1.52 | 12,016,364 |
| 2024-10-07 | Virsik Peter (Chief Operating Officer) | Sale | 694 | 6.03 | 4,184 |
| 2024-09-09 | Virsik Peter (Chief Operating Officer) | Sale | 694 | 6.00 | 4,164 |
| 2024-09-03 | Virsik Peter (Chief Operating Officer) | Sale | 2,082 | 6.03 | 12,554 |
| 2024-05-06 | Virsik Peter (Chief Operating Officer) | Sale | 694 | 6.95 | 4,823 |
| 2024-04-24 | Glickman Richard M | Option Ex | 3,750 | 4.90 | 18,375 |
| 2024-04-05 | Virsik Peter (Chief Operating Officer) | Sale | 694 | 7.94 | 5,510 |
| 2024-03-05 | Virsik Peter (Chief Operating Officer) | Sale | 694 | 8.98 | 6,232 |
| 2024-02-06 | Virsik Peter (Chief Operating Officer) | Sale | 72,782 | 10.29 | 748,926 |
| 2024-02-06 | Virsik Peter (Chief Operating Officer) | Option Ex | 72,782 | 3.23 | 235,085 |
| 2024-02-05 | Virsik Peter (Chief Operating Officer) | Sale | 1,194 | 9.64 | 11,516 |
| 2024-02-05 | Virsik Peter (Chief Operating Officer) | Option Ex | 500 | 3.23 | 1,615 |
| 2024-01-16 | Virsik Peter (Chief Operating Officer) | Sale | 1,718 | 10.01 | 17,197 |
| 2024-01-16 | Virsik Peter (Chief Operating Officer) | Option Ex | 1,718 | 3.23 | 5,549 |
| 2024-01-05 | Virsik Peter (Chief Operating Officer) | Sale | 699 | 6.11 | 4,270 |
| 2023-12-14 | Parkinson David Ross (Chief Executive Officer) | Buy | 9,223 | 2.30 | 21,212 |
| 2023-11-21 | Berger Franklin M | Buy | 23,259 | 5.73 | 133,274 |
| 2023-11-03 | Berger Franklin M | Buy | 16,471 | 5.99 | 98,661 |
| 2023-11-02 | Berger Franklin M | Buy | 60,000 | 5.35 | 321,000 |
| 2022-12-30 | Wood David S. (Chief Financial Officer) | Buy | 8,302 | 2.60 | 21,585 |
| 2022-12-30 | Parkinson David Ross (Chief Executive Officer) | Buy | 6,134 | 2.60 | 15,948 |
| 2022-12-22 | Parkinson David Ross (Chief Executive Officer) | Buy | 42,734 | 2.39 | 102,134 |
| 2022-12-21 | Berger Franklin M (Director) | Sale | 72,223 | 2.42 | 174,418 |
| 2022-12-20 | Berger Franklin M (Director) | Sale | 43,617 | 2.53 | 110,351 |
| 2022-12-16 | Berger Franklin M (Director) | Sale | 50,000 | 2.67 | 133,500 |
| 2022-12-15 | Berger Franklin M (Director) | Sale | 82,000 | 2.88 | 236,160 |
| 2022-12-14 | Berger Franklin M (Director) | Sale | 25,000 | 3.00 | 75,000 |
| 2022-10-27 | Bb Biotech Ag (10% Owner) | Buy | 500,000 | 4.50 | 2,251,000 |
| 2022-10-26 | Bb Biotech Ag (10% Owner) | Buy | 1,500,000 | 3.98 | 5,968,500 |
| 2022-07-18 | Bb Biotech Ag (10% Owner) | Buy | 300,000 | 3.16 | 946,800 |
| 2022-07-15 | Bb Biotech Ag (10% Owner) | Buy | 241,665 | 3.13 | 756,894 |
| 2022-07-14 | Bb Biotech Ag (10% Owner) | Buy | 347,204 | 2.79 | 969,393 |
| 2022-06-30 | Parkinson David Ross (Chief Executive Officer) | Buy | 4,887 | 2.96 | 14,455 |
| 2022-04-27 | Bb Biotech Ag (10% Owner) | Sale | 25,100 | 5.85 | 146,935 |
| 2021-08-18 | Bb Biotech Ag (10% Owner) | Buy | 250,000 | 8.88 | 2,218,750 |
| 2021-02-22 | Berger Franklin M (Director) | Buy | 57,000 | 27.00 | 1,539,000 |
| 2020-12-03 | Berger Franklin M (Director) | Option Ex | 42,207 | 3.94 | 166,379 |
Insider trading activities including stock purchases, stock sales, and option exercises of EPIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Essa Pharma Inc. (symbol EPIX, CIK number 1633932) see the Securities and Exchange Commission (SEC) website.